137 related articles for article (PubMed ID: 3392332)
1. Antagonism of quinidine's electrophysiologic effects by epinephrine in patients with ventricular tachycardia.
Morady F; Kou WH; Kadish AH; Nelson SD; Toivonen LK; Kushner JA; Schmaltz S; de Buitleir M
J Am Coll Cardiol; 1988 Aug; 12(2):388-94. PubMed ID: 3392332
[TBL] [Abstract][Full Text] [Related]
2. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone.
Calkins H; Sousa J; el-Atassi R; Schmaltz S; Kadish A; Morady F
J Am Coll Cardiol; 1992 Feb; 19(2):347-52. PubMed ID: 1732363
[TBL] [Abstract][Full Text] [Related]
3. Effects of epinephrine in patients with an accessory atrioventricular connection treated with quinidine.
Morady F; Kou WH; Kadish AH; Toivonen LK; Kushner JA; Schmaltz S
Am J Cardiol; 1988 Sep; 62(9):580-4. PubMed ID: 3414550
[TBL] [Abstract][Full Text] [Related]
4. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
[TBL] [Abstract][Full Text] [Related]
5. The effect of rate on prolongation of ventricular refractoriness by quinidine in humans.
Rosenheck S; Sousa J; Calkins H; Kadish AH; Morady F
Pacing Clin Electrophysiol; 1990 Nov; 13(11 Pt 1):1379-84. PubMed ID: 1701891
[TBL] [Abstract][Full Text] [Related]
6. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic effects of epinephrine in humans.
Morady F; Nelson SD; Kou WH; Pratley R; Schmaltz S; De Buitleir M; Halter JB
J Am Coll Cardiol; 1988 Jun; 11(6):1235-44. PubMed ID: 2835408
[TBL] [Abstract][Full Text] [Related]
8. Intravenous quinidine: relations among concentration, tachyarrhythmia suppression and electrophysiologic actions with inducible sustained ventricular tachycardia.
Duff HJ; Wyse DG; Manyari D; Mitchell LB
Am J Cardiol; 1985 Jan; 55(1):92-7. PubMed ID: 3966404
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
10. Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients with ventricular tachycardia.
Torres V; Flowers D; Miura D; Somberg J
Am Heart J; 1984 Dec; 108(6):1437-42. PubMed ID: 6507239
[TBL] [Abstract][Full Text] [Related]
11. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
Dorian P; Newman D; Berman N; Hardy J; Mitchell J
J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529
[TBL] [Abstract][Full Text] [Related]
12. Epinephrine-induced reversal of verapamil's electrophysiologic and therapeutic effects in patients with paroxysmal supraventricular tachycardia.
Morady F; Kou WH; Kadish AH; Toivonen LK; Kushner JA; Schmaltz S
Circulation; 1989 Apr; 79(4):783-90. PubMed ID: 2924411
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual comparison of intravenous ajmaline and quinidine in patients with sustained ventricular tachycardia: effects on normal myocardium and on arrhythmia characteristics.
Lengfelder W; Senges J; Rizos I; Jauernig R; Brachmann J; von Ohlshausen K; Kübler W
Eur Heart J; 1985 Apr; 6(4):312-22. PubMed ID: 4029187
[TBL] [Abstract][Full Text] [Related]
14. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
[TBL] [Abstract][Full Text] [Related]
15. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T
Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387
[TBL] [Abstract][Full Text] [Related]
16. The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate.
Rosenheck S; Schmaltz S; Kadish AH; Summitt J; Morady F
Am Heart J; 1991 Feb; 121(2 Pt 1):512-7. PubMed ID: 1990756
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
[TBL] [Abstract][Full Text] [Related]
19. The electrophysiologic effects of quinidine in the transplanted human heart.
Mason JW; Winkle RA; Rider AK; Stinson EB; Harrison DC
J Clin Invest; 1977 Mar; 59(3):481-9. PubMed ID: 320227
[TBL] [Abstract][Full Text] [Related]
20. Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia.
Sheldon RS; Rahmberg M; Duff HJ
J Cardiovasc Pharmacol; 1990 Nov; 16(5):818-23. PubMed ID: 1703606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
